Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Albert Deisseroth

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2012
U.S. Food and Drug Administration approval: ruxolitinib for the treatment of patients with intermediate and high-risk myelofibrosisAlbert Deisseroth, Edvardas Kaminskas, Joseph Grillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2020
Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic AnalysisKelly J Norsworthy, Flora Mulkey, Emma C Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2015
FDA Approval: BlinatumomabDonna Przepiorka, Chia-Wen Ko, Albert Deisseroth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2013
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myelomaThomas M Herndon, Albert Deisseroth, Edvardas Kaminskas, et al.
Journal of Translational Medicine|July 4, 2012
Considerations in the development of circulating tumor cell technology for clinical useDavid R Parkinson, Nicholas Dracopoli, Brenda Gumbs Petty, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2012
U.S. Food and Drug Administration approval: ruxolitinib for the treatment of patients with intermediate and high-risk myelofibrosisAlbert Deisseroth, Edvardas Kaminskas, Joseph Grillo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2020
Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic AnalysisKelly J Norsworthy, Flora Mulkey, Emma C Scott, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 17, 2015
FDA Approval: BlinatumomabDonna Przepiorka, Chia-Wen Ko, Albert Deisseroth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2013
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myelomaThomas M Herndon, Albert Deisseroth, Edvardas Kaminskas, et al.
Journal of Translational Medicine|July 4, 2012
Considerations in the development of circulating tumor cell technology for clinical useDavid R Parkinson, Nicholas Dracopoli, Brenda Gumbs Petty, et al.
Pageof 4